F Ripamonti
Impact in
- Pharmacology top 5%
- Microbial Natural Products and Biosynthesis
- Microbiology top 10%
- Antimicrobial Peptides and Activities
Papers in
-
- Bioactive Compounds and Antitumor Agents 3
- Pharmacology 12
- Microbial Natural Products and Biosynthesis 11
- Co-authors
- Beth P. GoldsteinMaurizio DenaroM BertiPietro FerrariEnrico SelvaRomeo CiabattiLuciano GastaldoPaolo Landini
- Journals
- The Journal of Antibiotics (5 papers)Antimicrobial Agents and Chemotherapy (4 papers)Journal of Antimicrobial Chemotherapy (1 paper)Biochemical Journal (1 paper)Journal of Medicinal Chemistry (1 paper)
- Partner nations
- ItalyUnited KingdomCzechia
In The Last Decade
F Ripamonti
18 papers receiving 480 citations
Peers
Comparison fields: 5 of 55
- Pharmacology 253
- Microbiology 60
- Toxicology 29
- Organic Chemistry 208
- Molecular Medicine 29
Countries citing papers authored by F Ripamonti
This map shows the geographic impact of F Ripamonti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F Ripamonti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F Ripamonti more than expected).
Fields of papers citing papers by F Ripamonti
This network shows the impact of papers produced by F Ripamonti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F Ripamonti. The network helps show where F Ripamonti may publish in the future.
Co-authors
The 25 scholars most cited alongside F Ripamonti, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1999 | 33 | |
| 2 | SYNTHESIS AND ACTIVITY STUDIES ON 3-(CARBOXYALKYLTHIO)RIFAMYCIN S DERIVATIVES | 1997 | 2 |
| 3 | 1997 | 11 | |
| 4 | 1997 | 53 | |
| 5 | 1996 | 6 | |
| 6 | Synthesis and antimicrobial activities of 4-purpuromycin derivatives. | 1996 | 8 |
| 7 | 1995 | 34 | |
| 8 | 1995 | 6 | |
| 9 | 1995 | 30 | |
| 10 | 1994 | 41 | |
| 11 | Chemical modifications of the antibiotic purpuromycin. | 1993 | 7 |
| 12 | 1993 | 18 | |
| 13 | 1992 | 7 | |
| 14 | 1992 | 29 | |
| 15 | 1991 | 155 | |
| 16 | 1987 | 93 | |
| 17 | 1983 | 4 | |
| 18 | 1979 | 4 |
About F Ripamonti
F Ripamonti is a scholar working on Toxicology, Pharmacology, Applied Microbiology and Biotechnology, Microbiology and Small Animals, having authored 18 papers that have together received 541 indexed citations. Recurring topics across this work include Microbial Natural Products and Biosynthesis (11 papers), Bioactive Compounds and Antitumor Agents (3 papers), Antimicrobial Resistance in Staphylococcus (3 papers), Antifungal resistance and susceptibility (2 papers), Antimicrobial Peptides and Activities (2 papers), Infectious Diseases and Mycology (2 papers), RNA and protein synthesis mechanisms (2 papers) and Carbohydrate Chemistry and Synthesis (2 papers). The work is most often cited by research in Pharmacology (253 citations), Microbiology (60 citations), Toxicology (29 citations), Organic Chemistry (208 citations) and Molecular Medicine (29 citations). F Ripamonti has collaborated with scholars based in Italy, United Kingdom and Czechia. Frequent co-authors include Beth P. Goldstein, Maurizio Denaro, M Berti, Pietro Ferrari, Enrico Selva, Romeo Ciabatti, Luciano Gastaldo, Paolo Landini, Lucio Montanaro and G. S. Saddler. Their work appears in journals such as The Journal of Antibiotics, Antimicrobial Agents and Chemotherapy, Journal of Antimicrobial Chemotherapy, Biochemical Journal and Journal of Medicinal Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.